Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 50090-6310

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 50090-6310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906310)

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules, 5 mg/2.5 mg, manufactured by A-S Medication Solutions. The label shows NDC 50090-6310-0 and indicates each capsule contains 5 mg chlordiazepoxide hydrochloride USP and 2.5 mg clidinium bromide USP. The package contains 30 capsules and includes storage instructions to store at controlled room temperature. The label also has lot and dosage information.*

FDA Label Image

Structure1 (Structure1)

Chemical structure of Chlordiazepoxide Hydrochloride, showing the molecular arrangement including chlorine atom, benzene ring, and other functional groups.*

FDA Label Image

Structure2 (Structure2)

Chemical structure diagram of Chlordiazepoxide Hydrochloride and Clidinium Bromide, showing the molecular arrangement including benzene rings, methyl groups, and bromide ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.